Why the study?
Disulfide-containing redox-sensitive strategies offer broad applicability and simple nanoparticle design to address current shortcomings in the intracellular delivery of nucleic acids.
This review summarizes the design and application of disulfide-containing nanomaterials to improve the intracellular delivery of nucleic acids.
These materials may address intracellular delivery barriers for nucleic acid therapies; leaves open clinical translation and cardiovascular validation.
Self-assembled nanostructures that are sensitive to environmental stimuli are promising nanomaterials for drug delivery. In this class, disulfide-containing redox-sensitive strategies have gained enormous attention because of their wide applicability and simplicity of nanoparticle design. In the context of nucleic acid delivery, numerous disulfide-based materials have been designed by relying on covalent or noncovalent interactions. In this review, we highlight major advances in the design of disulfide-containing materials for nucleic acid encapsulation, including covalent nucleic acid conjugates, viral vectors or virus-like particles, dendrimers, peptides, polymers, lipids, hydrogels, inorganic nanoparticles, and nucleic acid nanostructures. Our discussion will focus on the context of the design of materials and their impact on addressing the current shortcomings in the intracellular delivery of nucleic acids.
No takes yet. Share an insight, caveat, or question.
Dutta et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: